PLoS ONE · 2013 · 36 citations · 38 references
MedicineNeurologyNeuroscienceHepatologyIron Metabolism DisordersNeurochemistryCirrhosisHepatic PathophysiologyIron DeficiencyIron Deficiency DisordersIron MetabolismLiver DiseaseBody Iron StoresBrain Iron DeficiencyHepatic Iron AccumulationHepatic Iron StorageHepcidin Deficiency DisordersLiver Hepcidin RegulationSystemic Iron RegulationViral Hepatitis-related Cirrhosis
PURPOSE: Excessive brain iron accumulation contributes to cognitive impairments in hepatitis B virus (HBV)-related cirrhotic patients. The underlying mechanism remains unclear. Hepcidin, a liver-produced, 25-aminoacid peptide, is the major regulator of systemic iron metabolism. Abnormal hepcidin level is a key factor in some body iron accumulation or deficiency disorders, especially in those associated with liver diseases. Our study was aimed to explore the relationship between brain iron content in patients with HBV-related cirrhosis and serum hepcidin level. METHODS: Seventy HBV-related cirrhotic patients and forty age- sex-matched healthy controls were enrolled. Brain iron content was quantified by susceptibility weighted phase imaging technique. Serum hepcidin as well as serum iron, serum transferrin, ferritin, soluble transferrin receptor, total iron binding capacity, and transferrin saturation were tested in thirty cirrhotic patients and nineteen healthy controls. Pearson correlation analysis was performed to investigate correlation between brain iron concentrations and serum hepcidin, or other iron parameters. RESULTS: Cirrhotic patients had increased brain iron accumulation compared to controls in the left red nuclear, the bilateral substantia nigra, the bilateral thalamus, the right caudate, and the right putamen. Cirrhotic patients had significantly decreased serum hepcidin concentration, as well as lower serum transferring level, lower total iron binding capacity and higher transferrin saturation, compared to controls. Serum hepcidin level negatively correlated with the iron content in the right caudate, while serum ferritin level positively correlated with the iron content in the bilateral putamen in cirrhotic patients. CONCLUSIONS: Decreased serum hepcidin level correlated with excessive iron accumulation in the basal ganglia in HBV-related cirrhotic patients. Our results indicated that systemic iron overload underlined regional brain iron repletion. Serum hepcidin may be a clinical biomarker for brain iron deposition in cirrhotic patients, which may have therapeutic potential.
38
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Elizabeta Nemeth, Marie S. Tuttle, Julie Powelson et al. · Science · 2004 · 4.8K citations
Medicine, Cell Biology, Physiology +17
THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN
Bo Hallgren, Patrick Sourander · Journal of Neurochemistry · 1958 · 1.4K citations
Medicine, Neurobiology, Neuroscience +10
Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Christian Langkammer, Nikolaus Krebs, Walter Goessler et al. · Radiology · 2010 · 527 citations
Medicine, Neuroscience, Radiology +15
Subclinical hepatic encephalopathy impairs daily functioning
Michael Groeneweg, Juan C. Quero, Ilone De Bruijn et al. · Hepatology · 1998 · 503 citations · Full text
Measurements of iron status in patients with chronic hepatitis
Adrian M. Di Bisceglie, Constantine A. Axiotis, Jay H. Hoofnagle et al. · Gastroenterology · 1992 · 397 citations